Improving colon cancer therapy with a new promising small-molecule activator of the p53-pathway through disruption of p53-MDM2/MDMX interactions
Author(s) -
Liliana Raimundo,
Lucı́lia Saraiva,
Margarida Espadinha,
Joana Soares,
Joana B. Loureiro,
Juliana Calheiros,
Naïr Nazareth,
Joana Almeida,
Marco G. Alves,
Maria M. M. Santos
Publication year - 2019
Publication title -
proceedings of 7th international electronic conference on medicinal chemistry
Language(s) - English
Resource type - Conference proceedings
DOI - 10.3390/ecmc2019-06306
Subject(s) - mdmx , mdm2 , activator (genetics) , cancer research , cancer therapy , colorectal cancer , cancer , chemistry , medicine , apoptosis , biochemistry , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom